Longitudinal Trends in Stress-Related Endocrine Markers and Mental Health Outcomes Among Hospitalized Patients in Saudi Arabia Before, During, and After the COVID-19 Pandemic: A Retrospective Cohort Study
DOI:
https://doi.org/10.48047/CU/54/01/98-107Keywords:
Cortisol, DHEAS, COVID-19, Mental Health, Saudi Arabia, Retrospective StudyAbstract
Background: The COVID-19 pandemic imposed unprecedented challenges to healthcare and patient well-being worldwide, including Saudi Arabia, yet its long-term impact on stress-related endocrine markers and mental health has not been systematically assessed.
Objective: To determine the longitudinal changes in hair cortisol, DHEAS levels, and related mental health diagnoses before, during, and after the COVID-19 pandemic.
Methods: We conducted a retrospective cohort study of adult patients admitted to King Abdulaziz University Hospital in Jeddah, Saudi Arabia, from January 2019 to September 2024. We extracted demographic data, hair cortisol, DHEAS levels, cortisol/DHEAS ratios, and mental health diagnoses (anxiety, depression, and post-traumatic stress). Comparisons were made between pre-pandemic (2019), pandemic (2020–2021), and post-pandemic (2022–2024) periods using ANOVA, chi-square tests, and multivariable regression.
Results: Of 4,562 patients included hair cortisol and cortisol/DHEAS ratios were significantly elevated during the pandemic phase, accompanied by higher rates of anxiety and depression diagnoses. By the post-pandemic period, there was partial normalization of endocrine and mental health parameters, although values remained higher than pre-pandemic levels.
Conclusions: Our findings suggest that the pandemic triggered sustained alterations in stress biomarkers and mental health in this Saudi cohort. Continued efforts to support patients’ psychological and physiological recovery are warranted, underscoring the need for integrative post-pandemic healthcare interventions
Downloads
References
Staufenbiel, S.M.; Penninx, B.W.; Spijker, A.T.; Elzinga, B.M.; van Rossum, E.F. Hair cortisol, stress exposure, and mental health in humans: A systematic review. Psychoneuroendocrinology 2013, 38, 1220–1235.
O’Connor, D.B.; Thayer, J.F.; Vedhara, K. Stress and Health: A Review of Psychobiological Processes. Annu. Rev. Psychol. 2021, 72, 663–688.
Stalder, T.; Kirschbaum, C. Analysis of cortisol in hair—state of the art and future directions. Brain Behav. Immun. 2012, 26, 1019–1029.
Kamin, H.S.; Kertes, D.A. Cortisol and DHEA in development and psychopathology. Horm. Behav. 2017, 89, 69–85.
Boiko, A.S.; Mednova, I.A.; Kornetova, E.G.; Bokhan, N.A.; Semke, A.V.; Loonen, A.J.M.; Ivanova, S.A. Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia. Neuropsychiatr. Dis. Treat. 2020, 16, 1051–1058.
Mocking, R.J.; Pellikaan, C.M.; Lok, A.; Assies, J.; Ruhé, H.G.; Koeter, M.W.; Visser, I.; Bockting, C.L.; Olff, M.; Schene, A.H. DHEAS and cortisol/DHEAS ratio in recurrent depression: state or trait predicting 10-year recurrence? Psychoneuroendocrinology 2015, 59, 91–101.
Phillips, A.C.; Carroll, D.; Gale, C.R.; Lord, J.M.; Arlt, W.; Batty, G.D. Cortisol, DHEAS, their ratio, and the metabolic syndrome: Evidence from the Vietnam Experience Study. Eur. J. Endocrinol. 2010, 162, 919–923.
Cyr, S.; Marcil, M.J.; Marin, M.F.; Tardif, J.C.; Guay, S.; Guertin, M.C.; Rosa, C.; Genest, C.; Forest, J.; et al. Factors Associated with Burnout, Post-traumatic Stress, and Anxio-Depressive Symptoms in Healthcare Workers 3 Months into the COVID-19 Pandemic: An Observational Study. Front. Psychiatry 2021, 12, 668278.
Hu, C.; Chen, C.; Dong, X.P. Impact of the COVID-19 Pandemic on Patients with Neurodegenerative Diseases. Front. Aging Neurosci. 2021, 13, 664965.
Shreffler, J.; Petrey, J.; Huecker, M. The Impact of COVID-19 on Healthcare Worker Wellness: A Scoping Review. West. J. Emerg. Med. 2020, 21, 1059–1066.
Lethin, C.; Kenkmann, A.; Chiatti, C.; Christensen, J.; Backhouse, T.; Killett, A.; Fisher, O.; Malmgren Fänge, A. Organizational Support Experiences of Care Home and Home Care Staff in Sweden, Italy, Germany, and the United Kingdom during the COVID-19 Pandemic. Healthcare 2021, 9, 767.
Stalder, T.; Steudte-Schmiedgen, S.; Alexander, N.; Klucken, T.; Vater, A.; Wichmann, S.; Kirschbaum, C.; Miller, R. Stress-related and basic determinants of hair cortisol in humans: A meta-analysis. Psychoneuroendocrinology 2017, 77, 261–274.
Russell, E.; Koren, G.; Rieder, M.; Van Uum, S. Hair cortisol as a biological marker of chronic stress: Current status, future directions, and unanswered questions. Psychoneuroendocrinology 2012, 37, 589–601.
Dettenborn, L.; Muhtz, C.; Skoluda, N.; Stalder, T.; Steudte, S.; Hinkelmann, K.; Kirschbaum, C.; Otte, C. Introducing a novel method to assess cumulative steroid concentrations: Increased hair cortisol concentrations over 6 months in medicated patients with depression. Stress 2012, 15, 348–353.
Hennessey, E.P.; Kepinska, O.; Haft, S.L.; Chan, M.; Sunshine, I.; Jones, C.; Hancock, R.; Hoeft, F. Hair cortisol and dehydroepiandrosterone concentrations: Associations with executive function in early childhood. Biol. Psychol. 2020, 155, 107946.
Peng, F.J.; Palazzi, P.; Mezzache, S.; Bourokba, N.; Soeur, J.; Appenzeller, B.M.R. Profiling steroid and thyroid hormones with hair analysis in a cohort of women aged 25 to 45 years old. Eur. J. Endocrinol. 2022, 186, K9–K15.
Wright, K.D.; Ford, J.L.; Perazzo, J.; Jones, L.M.; Mahari, S.; Sullenbarger, B.A.; Laudenslager, M.L. Collecting Hair Samples for Hair Cortisol Analysis in African Americans. J. Vis. Exp. 2016, 136, 57288.
Davenport, M.D.; Tiefenbacher, S.; Lutz, C.K.; Novak, M.A.; Meyer, J.S. Analysis of endogenous cortisol concentrations in the hair of rhesus macaques. Gen. Comp. Endocrinol. 2006, 147, 255–261.
Phillips, A.C.; Carroll, D.; Gale, C.R.; Lord, J.M.; Arlt, W.; Batty, G.D. Cortisol, DHEA sulphate, their ratio, and all-cause and cause-specific mortality in the Vietnam Experience Study. Eur. J. Endocrinol. 2010, 163, 285–292.
Yanagita, I.; Fujihara, Y.; Kitajima, Y.; Tajima, M.; Honda, M.; Kawajiri, T.; Eda, T.; Yonemura, K.; Yamaguchi, N.; Asakawa, H.; et al. A High Serum Cortisol/DHEA-S Ratio Is a Risk Factor for Sarcopenia in Elderly Diabetic Patients. J. Endocr. Soc. 2019, 3, 801–813.
Carroll, D.; Phillips, A.C.; Lord, J.M.; Arlt, W.; Batty, G.D. Cortisol, dehydroepiandrosterone sulphate, their ratio, and hypertension: Evidence of associations in male veterans from the Vietnam Experience Study. J. Hum. Hypertens. 2011, 25, 418–424.
Lennartsson, A.K.; Sjörs, A.; Jonsdottir, I.H. Indication of attenuated DHEA-s response during acute psychosocial stress in patients with clinical burnout. J. Psychosom. Res. 2015, 79, 107–111.
Butcher, S.K.; Killampalli, V.; Lascelles, D.; Wang, K.; Alpar, E.K.; Lord, J.M. Raised cortisol:DHEAS ratios in the elderly after injury: Potential impact upon neutrophil function and immunity. Aging Cell 2005, 4, 319–324.
Mocking, R.J.; Pellikaan, C.M.; Lok, A.; Assies, J.; Olff, M.; Schene, A.H. DHEAS and cortisol/DHEAS ratio in recurrent depression: state or trait predicting 10-year recurrence? Psychoneuroendocrinology 2015, 59, 91–101.
Cho, S.; Park, W.J.; Kang, W.; Lim, H.M.; Ahn, J.S.; Lim, D.Y.; Moon, J.D. The association between serum dehydroepiandrosterone sulfate (DHEAS) levels and job-related stress among female nurses. Ann. Occup. Environ. Med. 2019, 31, e18.
Falco, A.; Girardi, D.; Elfering, A.; Peric, T.; Pividori, I.; Dal Corso, L. Is smart working beneficial for workers’ well-being? A Longitudinal Investigation of Smart Working, Workload, and Hair Cortisol/Dehydroepiandrosterone Sulfate during the COVID-19 Pandemic. Int. J. Environ. Res. Public Health 2023, 20, 6220.
Ibar, C.; Fortuna, F.; Gonzalez, D.; Jamardo, J.; Jacobsen, D.; Pugliese, L.; Giraudo, L.; Ceres, V.; Mendoza, C.; Repetto, E.M.; et al. Evaluation of stress, burnout, and hair cortisol levels in health workers at a university hospital during the COVID-19 pandemic. Psychoneuroendocrinology 2021, 128, 105213.
Shreffler, J.; Petrey, J.; Huecker, M. The Impact of COVID-19 on Healthcare Worker Wellness: A Scoping Review. West. J. Emerg. Med. 2020, 21, 1059–1066.
Lethin, C.; Kenkmann, A.; Chiatti, C.; et al. Organizational Support Experiences of Care Home and Home Care Staff in Sweden, Italy, Germany, and the UK during COVID-19. Healthcare 2021, 9, 767.
Hirokawa, K.; Fujii, Y.; Taniguchi, T.; Takaki, J.; Tsutsumi, A. Association Between Cortisol to DHEA-s Ratio and Sickness Absence in Japanese Male Workers. Int. J. Behav. Med. 2018, 25, 362-467.
Maninger, N.; Wolkowitz, O.M.; Reus, V.I.; Epel, E.S.; Mellon, S.H. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front. Neuroendocrinol. 2009, 30, 65–91.
Pan, X.; Wu, X.; Kaminga, A.C.; Wen, S.W.; Liu, A. Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate in Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Front. Aging Neurosci. 2019, 11, 61.
Yiallouris, A.; Tsioutis, C.; Agapidaki, E.; Zafeiri, M.; Agouridis, A.P.; Ntourakis, D.; Johnson, E.O. Adrenal Aging and Its Implications on Stress Responsiveness in Humans. Front. Endocrinol. 2019, 10, 54.
Wu, T.T.; Chen, Y.; Zhou, Y.; Adi, D.; Zheng, Y.Y.; Liu, F.; Ma, Y.T.; Xie, X. Prognostic Value of Dehydroepiandrosterone Sulfate for Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis. J. Am. Heart Assoc. 2017, 6, e004896.
Hosseini Moghaddam, M.; Mohebbi, Z.; Tehranineshat, B. Stress management in nurses caring for COVID-19 patients: A qualitative content analysis. BMC Psychol. 2022, 10, 124.
Łuc, M.; Pawłowski, M.; Jaworski, A.; Fila-Witecka, K.; Szcześniak, D.; Augustyniak-Bartosik, H.; Zielińska, D.; Stefaniak, A.; Pokryszko-Dragan, A.; Chojdak-Łukasiewicz, J.; et al. Coping of Chronically Ill Patients during the COVID-19 Pandemic: Comparison between Four Groups. Int. J. Environ. Res. Public Health 2023, 20, 4814.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Author

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.